Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDUSTRY × Solid Neoplasms × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1607 Breast Neoplasms 1186 Carcinoma, Non-Small-Cell Lung 960 Prostatic Neoplasms 616 Colorectal Neoplasms 570 Neoplasm Metastasis 543 Multiple Myeloma 460 Melanoma 446 Ovarian Neoplasms 371 Lung Neoplasms 365 Lymphoma 319 Lymphoma, Non-Hodgkin 314 Leukemia, Myeloid, Acute 310 Recurrence 306 Pancreatic Neoplasms 296 Carcinoma, Renal Cell 286 Carcinoma, Hepatocellular 240 Stomach Neoplasms 227 Leukemia, Lymphocytic, Chronic, B-Cell 227 Lymphoma, Follicular 218 Head and Neck Neoplasms 199 Leukemia 182 Glioblastoma 179 Urinary Bladder Neoplasms 148 Carcinoma 148 Lymphoma, Large B-Cell, Diffuse 147 Small Cell Lung Carcinoma 144 Uterine Cervical Neoplasms 143 Squamous Cell Carcinoma of Head and Neck 143 Keratosis, Actinic 140

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03364049 2021-11-15

MK-7162-002

Merck Sharp & Dohme LLC

Phase 1 Completed

33 enrolled 19 charts

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡